Journal article

Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants

Prema Subramaniam, Jacqueline J Ho, Peter G Davis

COCHRANE DATABASE OF SYSTEMATIC REVIEWS | WILEY | Published : 2016

Abstract

BACKGROUND: Cohort studies have suggested that nasal continuous positive airways pressure (CPAP) starting in the immediate postnatal period before the onset of respiratory disease (prophylactic CPAP) may be beneficial in reducing the need for intubation and intermittent positive pressure ventilation (IPPV) and in preventing bronchopulmonary dysplasia (BPD) in preterm or low birth weight infants. OBJECTIVES: To determine if prophylactic nasal CPAP started soon after birth regardless of respiratory status in the very preterm or very low birth weight infant reduces the use of IPPV and the incidence of bronchopulmonary dysplasia (BPD) without adverse effects. SEARCH METHODS: We used the standard..

View full abstract

Grants

Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA


Funding Acknowledgements

Internal sourcesDepartment of Paediatrics, Ipoh Hospital, Ipoh, Malaysia.Penang Medical College, Malaysia.Royal Women's Hospital, Melbourne, Australia.Royal Prince Alfred Hospital, Sydney, Australia.Centre for Perinatal Health Services Research, University of Sydney, Australia.External sourcesEunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA.Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201100016C